Interações medicamentosas
Ado-trastuzumab + Rozanolixizumab
Gravidade: Moderada
Ado-trastuzumab and Rozanolixizumab: moderate interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Rozanolixizumab blocks the neonatal Fc receptor, which lowers circulating IgG levels. Ado-trastuzumab emtansine is an IgG1 antibody conjugate, so its exposure and efficacy could theoretically be reduced.
O que esta interação significa em palavras simples
Ado-trastuzumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Ado-trastuzumab belongs to Oncology; Rozanolixizumab belongs to Miscellaneous.
Por que acontece
FcRn blockade increases catabolism of IgG-based therapeutics such as trastuzumab emtansine.
O que fazer
Monitor for reduced response to trastuzumab emtansine. Time rozanolixizumab cycles away from treatment where possible, or consider alternatives.
O que perguntar ao farmacêutico
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Ado-trastuzumab e Rozanolixizumab, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Outras interações de Ado-trastuzumab
Outras interações de Rozanolixizumab
- Rozanolixizumab + Upadacitinib Grave
- Abatacept + Rozanolixizumab Moderada
- Adalimumab + Rozanolixizumab Moderada
- Basiliximab + Rozanolixizumab Moderada
- Bevacizumab + Rozanolixizumab Moderada
- Denosumab + Rozanolixizumab Moderada
Perguntas frequentes
Can I take Ado-trastuzumab with Rozanolixizumab?
MediHelp rates the interaction as moderate. Ado-trastuzumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, which lowers circulating IgG levels. Ado-trastuzumab emtansine is an IgG1 antibody conjugate, so its exposure and efficacy could theoretically be reduced.
How serious is the interaction between Ado-trastuzumab and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced response to trastuzumab emtansine. Time rozanolixizumab cycles away from treatment where possible, or consider alternatives.
What other medicines interact with Ado-trastuzumab?
MediHelp also lists interactions of Ado-trastuzumab with, for example, Atazanavir, Baricitinib, Ceritinib. The full list is on the Ado-trastuzumab page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
